Results 161 to 170 of about 158,149 (351)
Effects of baseline mitral regurgitation in the CABANA trial: randomization to catheter ablation versus drug therapy in patients with atrial fibrillation. AF, atrial fibrillation; CCS, Canadian Cardiovascular Society; MR, mitral regurgitation; NYHA, New York Heart Association; OR, odds ratio.
Sebastiaan Dhont+8 more
wiley +1 more source
Long-term outcome after mitral valve repair: a risk factor analysis [PDF]
Objective: Mitral valve repair is the gold standard to restore mitral valve function and is now known to have good long-term outcome. In order to help perioperative decision making, we analyzed our collective to find independent risk factors affecting ...
Eisa, Karam+5 more
core
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
M. Mack+17 more
semanticscholar +1 more source
On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Ferrari, Enrico+3 more
core
Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...
Laura Lupi+17 more
wiley +1 more source
Management of tricuspid regurgitation in patients undergoing mitral valve replacement for rheumatic mitral valve diseases [PDF]
BACKGROUND: In mitral valve diseases associated with long standing pulmonary hypertension,Tricuspid annulus dilates and fails to shorten during systole leading to Tricuspid regurgitation.Tricuspid regurgitation contributes to both the morbidity and ...
Prasanna, R
core
Percutaneous Mitral Valve Repair
Nonsurgical treatment of clinically important mitral regurgitation (MR) has evolved tremendously over the past decade. Recent studies of percutaneous mitral valve repair procedures have shown that less invasive procedures are safe and can be effective in selected patients. MitraClip has been studied most extensively.
openaire +3 more sources
Impact of mitral transcatheter edge‐to‐edge repair (M‐TEER) on left and right heart function. IQR, interquartile range; LA, left atrial; RVEF, right ventricular ejection fraction; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion. Abstract Aims Long‐standing severe mitral regurgitation (MR) leads to left atrial
Vera Fortmeier+21 more
wiley +1 more source
In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).
Philipp von Stein+70 more
wiley +1 more source
Dynamic Assessment of Mitral Valve Repair by Directing Pump Blood into the Left Ventricle [PDF]
S. Balasundaram, M. Kassay, Cmg Duran
openalex +1 more source